Covered recipient · General Payments record
SARAH S FLETCHER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2025
$1,478.38
- Reported across 82 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $192.81 | 10 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $36.21 | 2 |
| IBSA Pharma Inc. | $32.06 | 2 |
| Acerta Pharma LLC | $27.39 | 1 |
| Exact Sciences Corporation | $23.61 | 1 |
| ABBVIE INC. | $21.21 | 1 |
| Novo Nordisk AS | $19.16 | 1 |
| Alnylam Pharmaceuticals Inc. | $18.49 | 1 |
| Acella Pharmaceuticals, LLC | $14.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.21 | 04/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201863826 | CMS |
| Acella Pharmaceuticals, LLC | $14.68 | 04/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241767795 | CMS |
| Alnylam Pharmaceuticals Inc. | $18.49 | 04/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1212786612 | CMS |
| AstraZeneca Pharmaceuticals LP | $27.39 | 08/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206621612 | CMS |
| Exact Sciences Corporation | $23.61 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235255239 | CMS |
| IBSA Pharma Inc. | $14.62 | 04/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1211690208 | CMS |
| IBSA Pharma Inc. | $17.44 | 09/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1211693771 | CMS |
| Novo Nordisk Inc | $19.16 | 08/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188895091 | CMS |
| PFIZER INC. | $14.25 | 03/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231490805 | CMS |
| PFIZER INC. | $21.96 | 05/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231729420 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.